|
DYNC2LI1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.777600E-04 |
| Normal-vs-Stage3 |
1.252180E-01 |
| Normal-vs-Stage4 |
2.338600E-01 |
| Stage1-vs-Stage2 |
8.560600E-01 |
| Stage1-vs-Stage3 |
2.200800E-04 |
| Stage1-vs-Stage4 |
6.969800E-02 |
| Stage2-vs-Stage3 |
6.019100E-03 |
| Stage2-vs-Stage4 |
1.520560E-01 |
| Stage3-vs-Stage4 |
5.817600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.58139999983931E-08 |
| Normal-vs-Asian |
5.761400E-01 |
| Caucasian-vs-AfricanAmerican |
7.067600E-01 |
| Caucasian-vs-Asian |
7.531800E-02 |
| AfricanAmerican-vs-Asian |
1.038210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.33459999998686E-07 |
| Male-vs-Female |
7.133700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.758160E-04 |
| Normal-vs-Extreme_Weight |
1.83963955180388E-12 |
| Normal-vs-Obese |
2.20189999566855E-09 |
| Normal-vs-Extreme_Obese |
2.181500E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.016190E-02 |
| Normal_Weight-vs-Obese |
5.827700E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.179400E-01 |
| Extreme_Weight-vs-Obese |
5.148200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.075200E-01 |
| Obese-vs-Extreme_Obese |
9.324600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.698100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(61-80Yrs) |
3.33066907387547E-15 |
| Normal-vs-Age(81-100Yrs) |
6.462000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.971990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.012800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.742400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.360800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.884200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.391020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.020770E-01 |
| Normal-VS-KIRP CIMP |
7.451800E-01 |
| Normal-VS-Unclassified PRCC |
9.73619999999897E-05 |
| Type1 PRCC-VS-Type2 PRCC |
<1E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.99760216648792E-15 |
| Type1 PRCC-VS-Unclassified PRCC |
2.007500E-04 |
| Type2 PRCC-VS-KIRP CIMP |
8.615800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.863520E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.40800000000419E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.192000E-04 |
| Normal-vs-N1 |
2.117400E-01 |
| Normal-vs-N2 |
7.404400E-01 |
| N0-vs-N1 |
1.220220E-01 |
| N0-vs-N2 |
3.439800E-01 |
| N1-vs-N2 |
7.181600E-01 |
|
|
